Cargando…

Prediction of overall survival for metastatic pancreatic cancer: Development and validation of a prognostic nomogram with data from open clinical trial and real‐world study

It is necessary to develop prognostic tools of metastatic pancreatic cancer (MPC) for optimizing therapeutic strategies. Thus, we tried to develop and validate a prognostic nomogram of MPC. Data from 3 clinical trials (NCT00844649, NCT01124786, and NCT00574275) and 133 Chinese MPC patients were used...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hang, Junjie, Wu, Lixia, Zhu, Lina, Sun, Zhiqiang, Wang, Ge, Pan, Jingjing, Zheng, Suhua, Xu, Kequn, Du, Jiadi, Jiang, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051216/ https://www.ncbi.nlm.nih.gov/pubmed/29856121 http://dx.doi.org/10.1002/cam4.1573

Ejemplares similares

The clinical implication of CD45RA(+) naïve T cells and CD45RO(+) memory T cells in advanced pancreatic cancer: a proxy for tumor biology and outcome prediction
por: Hang, Junjie, et al.
Publicado: (2019)

Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer
por: Su, Yung-Yeh, et al.
Publicado: (2023)

Clinical significance of site-specific metastases in pancreatic cancer: a study based on both clinical trial and real-world data
por: Wu, Lixia, et al.
Publicado: (2021)

Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer
por: Goldstein, David, et al.
Publicado: (2020)

A nomogram based on CT texture features to predict the response of patients with advanced pancreatic cancer treated with chemotherapy
por: Li, Jingjing, et al.
Publicado: (2023)

Nomogram forecasting 3‐, 5‐, and 8‐year overall survival and cancer‐specific survival of gingival squamous cell carcinoma
por: Yan, Lei, et al.
Publicado: (2020)

Nomograms for predicting specific distant metastatic sites and overall survival of colorectal cancer patients: A large population‐based real‐world study
por: Mo, Shaobo, et al.
Publicado: (2020)

Real‐world prognostic factors for survival among treated patients with metastatic pancreatic ductal adenocarcinoma
por: Yu, Kenneth H., et al.
Publicado: (2021)

New nomograms to predict overall and cancer‐specific survival of angiosarcoma
por: Liu, Yuan‐Yuan, et al.
Publicado: (2021)

Real-world Treatment Patterns and Overall Survival in Locally Advanced and Metastatic Urothelial Tract Cancer Patients Treated with Chemotherapy in Denmark in the Preimmunotherapy Era: A Nationwide, Population-based Study
por: Omland, Lise H., et al.
Publicado: (2020)

Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020)

Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer
por: Bando, Etsuro, et al.
Publicado: (2020)

Real‐world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia
por: Sun, James, et al.
Publicado: (2021)

Comparative Effectiveness of Palliative Chemotherapy in Metastatic Breast Cancer: A Real‐World Evidence Analysis
por: Feinberg, Bruce, et al.
Publicado: (2020)

Real‐World Adherence in Patients with Metastatic Colorectal Cancer Treated with Trifluridine plus Tipiracil or Regorafenib
por: Patel, Anuj K., et al.
Publicado: (2019)

Prognostic nomograms to predict overall survival and cancer‐specific survival in patients with pelvic chondrosarcoma
por: Chen, Li, et al.
Publicado: (2019)

Construction and validation of a nomogram to predict overall survival in patients with inflammatory breast cancer
por: Diao, Jian‐dong, et al.
Publicado: (2019)

Real-world Treatment Patterns and Clinical Outcomes for Metastatic Renal Cell Carcinoma in the Current Treatment Era
por: Shah, Neil J., et al.
Publicado: (2023)

Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic Breast Cancer
por: Rugo, Hope S, et al.
Publicado: (2023)

Development and validation of a nomogram predicting the overall survival of stage IV breast cancer patients
por: Li, Shunrong, et al.
Publicado: (2017)

Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort
por: Zschäbitz, Stefanie, et al.
Publicado: (2023)

A real‐world, population‐based study of patterns of referral, treatment, and outcomes for advanced pancreatic cancer
por: Abdel‐Rahman, Omar, et al.
Publicado: (2018)

Role of CT texture features for predicting outcome of pancreatic cancer patients with liver metastases
por: Hang, Junjie, et al.
Publicado: (2021)

Nomograms for predicting long‐term overall survival and cancer‐specific survival in lip squamous cell carcinoma: A population‐based study
por: Hu, Chuan-Yu, et al.
Publicado: (2019)

Nomograms forecasting long‐term overall and cancer‐specific survival of patients with oral squamous cell carcinoma
por: Wang, Fengze, et al.
Publicado: (2018)

Real-World Treatment Patterns Among Patients With Metastatic Castration-Resistant Prostate Cancer: Results From an International Study
por: Barata, Pedro C, et al.
Publicado: (2023)

Real-World Treatment Trends Among Patients with Metastatic Castration-Sensitive Prostate Cancer: Results from an International Study
por: Barata, Pedro C, et al.
Publicado: (2023)

Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer‐specific survival of patients with kidney cancer
por: Zhou, Yuan, et al.
Publicado: (2020)

Surrogate Endpoints as Predictors of Overall Survival in Metastatic Urothelial Cancer: A Trial-level Analysis
por: Ghali, Fady, et al.
Publicado: (2022)

Nomogram for predicting overall survival in patients with large (>5 cm) hepatocellular carcinoma based on real-world practice
por: Kim, Nalee, et al.
Publicado: (2023)

Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer
por: Miyoshi, Yasuhide, et al.
Publicado: (2015)

Development and validation of novel nomograms for predicting the survival of patients after surgical resection of pancreatic ductal adenocarcinoma
por: Li, Ge, et al.
Publicado: (2020)

Nomograms to estimate long‐term overall survival and tongue cancer‐specific survival of patients with tongue squamous cell carcinoma
por: Li, Yun, et al.
Publicado: (2017)

Nomogram prediction of overall survival based on log odds of positive lymph nodes for patients with penile squamous cell carcinoma
por: Zheng, Wenwen, et al.
Publicado: (2020)

Evaluating overall survival and competing risks of survival in patients with early‐stage breast cancer using a comprehensive nomogram
por: Xu, Yan‐Bo, et al.
Publicado: (2020)

Real-World Experience with CDK4/6 Inhibitors for Metastatic HR+/HER2− Breast Cancer at a Single Cancer Center
por: Knudsen, Erik S, et al.
Publicado: (2022)

Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real‐world database
por: Mailliez, Audrey, et al.
Publicado: (2022)

Rituximab maintenance improves overall survival in follicular lymphoma: A retrospective nationwide real‐world analysis from Taiwan Cancer Registry Database
por: Huang, Huai‐Hsuan, et al.
Publicado: (2018)

Association between patient‐initiated emails and overall 2‐year survival in cancer patients undergoing chemotherapy: Evidence from the real‐world setting
por: Coquet, Jean, et al.
Publicado: (2020)

Construction of a nomogram predicting the overall survival of patients with distantly metastatic non-small-cell lung cancer
por: Deng, Jianqing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lh7u32avrjcq2cgv4uhl60up8e